Cargando…

Coronary artery calcification in patients with advanced chronic kidney disease

INTRODUCTION: Cardiovascular disease (CVD) is associated with higher morbidity and mortality rates in patients with chronic kidney disease (CKD). Studies have shown that vascular calcification is a major predictor of CVD. Vascular calcification in the CKD population is associated with various risk f...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Xiadan, He, Ji, Zhang, Wei, He, Qiang, Liu, Yueming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618197/
https://www.ncbi.nlm.nih.gov/pubmed/36309659
http://dx.doi.org/10.1186/s12872-022-02879-0
_version_ 1784820997300420608
author Xiang, Xiadan
He, Ji
Zhang, Wei
He, Qiang
Liu, Yueming
author_facet Xiang, Xiadan
He, Ji
Zhang, Wei
He, Qiang
Liu, Yueming
author_sort Xiang, Xiadan
collection PubMed
description INTRODUCTION: Cardiovascular disease (CVD) is associated with higher morbidity and mortality rates in patients with chronic kidney disease (CKD). Studies have shown that vascular calcification is a major predictor of CVD. Vascular calcification in the CKD population is associated with various risk factors, and changes in bone and mineral metabolism have been linked to an increased risk of atherosclerosis. Therefore, we aimed to investigate the correlation between vascular calcification and bone metabolism, which is necessary to improve the survival and prognosis of patients with CKD. METHODS: We included 146 patients with CKD who received coronary artery calcification (CAC) scores at our hospital from May 2017 to November 2018. Spearman rank correlation analysis, Mann–Whitney U test, and Kaplan–Meier method were used to analyze laboratory data and all-cause mortality. RESULTS: In the 146 patients, chronic glomerulonephritis accounted for the most common cause of CKD, at approximately 39.0%. Spearman rank correlation analysis on the factors influencing vascular calcification in patients with CKD showed that CAC score was significantly and positively correlated with C-reactive protein, N-terminal/midregion osteocalcin (N-MID), N-terminal peptide of type 1 procollagen (P1NP), β-cross-linked C-telopeptide of type 1 collagen (β-CTx), and parathyroid hormone (P = 0.0423, P = 0.0432, P = 0.0235, P = 0.0061, P < 0.0001, respectively). Serum calcium levels were positively correlated with N-MID, P1NP, β-CTx, and iPTH (r = 0.19, r = 0.24, r = 0.21, r = 0.21, respectively), and serum phosphorus levels were positively correlated with N-MID, P1NP, β-CTx, and iPTH (r = 0.50, r = 0.37, r = 0.50, r = 0.55, respectively). However, no difference was found in CVC scores among patients with CKD in different stages and receiving different treatments. In the Kaplan–Meier analysis of all-cause hospitalization and mortality rates, patients with CAC > 400 had a higher risk. CONCLUSION: We found that the primary cause of CKD is glomerulonephritis, and the CAC score is positively correlated with inflammatory and bone metabolism markers, with a higher risk of all-cause mortality and cardiovascular hospitalization when the CAC score is greater than 400.
format Online
Article
Text
id pubmed-9618197
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96181972022-10-31 Coronary artery calcification in patients with advanced chronic kidney disease Xiang, Xiadan He, Ji Zhang, Wei He, Qiang Liu, Yueming BMC Cardiovasc Disord Research INTRODUCTION: Cardiovascular disease (CVD) is associated with higher morbidity and mortality rates in patients with chronic kidney disease (CKD). Studies have shown that vascular calcification is a major predictor of CVD. Vascular calcification in the CKD population is associated with various risk factors, and changes in bone and mineral metabolism have been linked to an increased risk of atherosclerosis. Therefore, we aimed to investigate the correlation between vascular calcification and bone metabolism, which is necessary to improve the survival and prognosis of patients with CKD. METHODS: We included 146 patients with CKD who received coronary artery calcification (CAC) scores at our hospital from May 2017 to November 2018. Spearman rank correlation analysis, Mann–Whitney U test, and Kaplan–Meier method were used to analyze laboratory data and all-cause mortality. RESULTS: In the 146 patients, chronic glomerulonephritis accounted for the most common cause of CKD, at approximately 39.0%. Spearman rank correlation analysis on the factors influencing vascular calcification in patients with CKD showed that CAC score was significantly and positively correlated with C-reactive protein, N-terminal/midregion osteocalcin (N-MID), N-terminal peptide of type 1 procollagen (P1NP), β-cross-linked C-telopeptide of type 1 collagen (β-CTx), and parathyroid hormone (P = 0.0423, P = 0.0432, P = 0.0235, P = 0.0061, P < 0.0001, respectively). Serum calcium levels were positively correlated with N-MID, P1NP, β-CTx, and iPTH (r = 0.19, r = 0.24, r = 0.21, r = 0.21, respectively), and serum phosphorus levels were positively correlated with N-MID, P1NP, β-CTx, and iPTH (r = 0.50, r = 0.37, r = 0.50, r = 0.55, respectively). However, no difference was found in CVC scores among patients with CKD in different stages and receiving different treatments. In the Kaplan–Meier analysis of all-cause hospitalization and mortality rates, patients with CAC > 400 had a higher risk. CONCLUSION: We found that the primary cause of CKD is glomerulonephritis, and the CAC score is positively correlated with inflammatory and bone metabolism markers, with a higher risk of all-cause mortality and cardiovascular hospitalization when the CAC score is greater than 400. BioMed Central 2022-10-29 /pmc/articles/PMC9618197/ /pubmed/36309659 http://dx.doi.org/10.1186/s12872-022-02879-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xiang, Xiadan
He, Ji
Zhang, Wei
He, Qiang
Liu, Yueming
Coronary artery calcification in patients with advanced chronic kidney disease
title Coronary artery calcification in patients with advanced chronic kidney disease
title_full Coronary artery calcification in patients with advanced chronic kidney disease
title_fullStr Coronary artery calcification in patients with advanced chronic kidney disease
title_full_unstemmed Coronary artery calcification in patients with advanced chronic kidney disease
title_short Coronary artery calcification in patients with advanced chronic kidney disease
title_sort coronary artery calcification in patients with advanced chronic kidney disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618197/
https://www.ncbi.nlm.nih.gov/pubmed/36309659
http://dx.doi.org/10.1186/s12872-022-02879-0
work_keys_str_mv AT xiangxiadan coronaryarterycalcificationinpatientswithadvancedchronickidneydisease
AT heji coronaryarterycalcificationinpatientswithadvancedchronickidneydisease
AT zhangwei coronaryarterycalcificationinpatientswithadvancedchronickidneydisease
AT heqiang coronaryarterycalcificationinpatientswithadvancedchronickidneydisease
AT liuyueming coronaryarterycalcificationinpatientswithadvancedchronickidneydisease